Praxis Precision Medicines (PRAX) Treasury Shares (2019 - 2026)

Praxis Precision Medicines' Treasury Shares history runs 8 years deep, the most recent figure standing at $131802.0 for Q1 2026.

• On a quarterly basis, Treasury Shares fell 74.76% year-over-year to $131802.0 in Q1 2026; TTM through Mar 2026 was $131802.0, a 74.76% decrease from a year earlier, with the FY2024 full-year figure at $224473.0, up 376.13% from the prior year.
• Treasury Shares fell to $131802.0 in Q1 2026 per PRAX's latest filing, from $516119.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $856287.0 in Q2 2022 and bottomed at $47145.0 in Q4 2023.
• The 5-year median for Treasury Shares is $515857.5 (2025), against an average of $435025.8.
• Across the five-year window, Treasury Shares plunged 88.74% in 2022 and jumped 435.09% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $49565.0 in 2022, then retreated by 4.88% to $47145.0 in 2023, then soared by 376.13% to $224473.0 in 2024, then jumped by 129.92% to $516119.0 in 2025, then tumbled by 74.46% to $131802.0 in 2026.
• Per Business Quant, the three latest PRAX Treasury Shares figures stand at $131802.0 (Q1 2026), $516119.0 (Q3 2025), and $515596.0 (Q2 2025).